PrescribeIT is shutting down: what Canadian pharmacies and clinics need to know.

Canada Health Infoway's PrescribeIT service ends at 11:59 PM EST on May 29, 2026. After more than $250 million in federal investment since 2017 and an adoption rate that never crossed 5% of Canadian prescriptions, the national e-prescribing service is winding down. This brief covers what changes, why, who it affects, and what comes next.

What is shutting down

PrescribeIT is the federally funded electronic prescription transmission service operated by Canada Health Infoway. It connected EMR systems used by prescribers (OSCAR Pro, Accuro QHR, TELUS PS Suite, Microquest, WELL Health and others) to pharmacy management systems (Kroll, Filware, Nexxsys, Propel Rx) so prescriptions could move electronically from clinic to pharmacy.

At 11:59 PM EST on May 29, 2026, the service stops accepting and transmitting prescriptions. Renewal requests, cancellations, dispense-status updates, and secure clinical messaging — all of which previously flowed through PrescribeIT — also stop on the same date.

Why it's being shut down

Canada Health Infoway cited low adoption and unsustainable funding. After eight years of operation, fewer than 5% of Canadian prescriptions ever flowed through the service (Globe and Mail, 2026). A $0.20-per-prescription pharmacy fee introduced in 2025 was the final blow: a 2024 survey of 1,300 Canadian pharmacists conducted by the Canadian Pharmacists Association found that 65% would stop using PrescribeIT if a fee was added (Canadian Healthcare Network). Most pharmacies followed through. The federal government chose not to continue funding the program and the provinces declined to share the cost.

Who is affected

Three audiences feel the shutdown directly:

• Canadian pharmacies on Kroll (TELUS Health), Filware, Nexxsys, and Propel Rx that were receiving electronic prescriptions through PrescribeIT — most prescriptions revert to fax until vendor implementations of the new open standard catch up.
• Canadian clinics and prescribers on every major EMR — OSCAR Pro, Accuro QHR, TELUS PS Suite, Microquest, WELL Health — that were sending electronic prescriptions through PrescribeIT. Their EMR workflow stays the same; the transmission layer disappears.
• FreedomRx users — Accuro EMR clinics and Loblaw / Shoppers Drug Mart pharmacies — face the same workflow disruption four weeks earlier, when QHR Technologies retires FreedomRx on May 1, 2026 (QHR Technologies notice).

What comes next

Canada Health Infoway is publishing a national e-prescribing open standard on May 1, 2026. The standard will be maintained by Infoway from May 30 onward and is intended for adoption by EMR and pharmacy management system vendors. Realistic vendor implementation timelines run 6 to 18 months — most prescription workflows will operate on fax in the interim.

Provincial regulatory changes follow as well. In Alberta, the College of Pharmacy has confirmed that TPP Type 1 prescriptions revert to physical secure prescription pads starting May 30, 2026 unless the prescriber's facility has an exemption (Alberta College of Pharmacy). Similar provincial reversals are likely in other jurisdictions.

What pharmacies and clinics can do today

For pharmacies: the immediate concern is incoming fax volume. Prescriptions that previously arrived as structured electronic data now arrive as faxes that must be manually transcribed into the pharmacy management system. For a typical 200-Rx/day community pharmacy on Kroll, that translates to 5–8 hours of additional staff data-entry time per day. See our pharmacy-side guide at /pharmacists/.

For clinics: the immediate concern is the loss of bidirectional workflows — renewal requests, cancellations, and dispense status — that PrescribeIT carried. Prescription writing inside the EMR continues unchanged; the gap is in transmission and the round-trip back to the prescriber. See our clinic-side guide at /clinicians/.

For FreedomRx users on Accuro EMR or in the Loblaw / Shoppers Drug Mart network, the parallel guide is at /freedomrx-alternative/.

About this brief

This page is published by AutoRx Solutions Inc., a Canadian-owned company. We are an independent business — not affiliated with Canada Health Infoway, TELUS Health, QHR Technologies, or Loblaw Companies. We do operate one of the replacement services Canadian pharmacies and clinics are switching to; the editorial disclosure on our alternatives comparison explains how we cover competitors.

Have a correction, additional data, or want to be interviewed for follow-up coverage? Email [email protected] or see the press kit for cited facts, spokesperson roles, and pre-cleared quotes available for direct attribution.